Chicago (ots/PRNewswire) - Cardiac Dimensions.
1. Magne, Pibarot, Dagenais, et al. Preoperative posterior leaflet angle accurately predicts outcome after restrictive Mitralklappe annuloplasty for ischemic mitral regurgitation. Circulation. 2007;115:782-791 2. Ponikowski P, Anker SD, AlHabib KF et al. Heart failure: preventing disease and death worldwide. ESC Heart Failure. 2014;1:4-25. 3. Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the Impact of Heart Failure in the United States. Circ Heart Fail. 2013;6(3):606-19. 4. Hoppe UC, Brandt MC, Degen H, et al. Percutaneous mitral annuloplasty device leaves free access to cardiac veins for resynchronization therapy. Catheter Cardiovasc Interv. 2009;74(3):506-11. 5. Latib, A. "Coronary Sinus Annuloplasty." New York, Montefiore Medical Center. 6. Lipiecki J, Siminiak T, Sievert H, et al. Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: TITAN II trial. BMJ Open Heart. 2016;3 7. Siminiak T, et. al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: Results of the TITAN Trial. Eur J Heart Fail. 2012;14:931-38. 8. Sievert, H. 2018. REDUCE-FMR: Sham Controlled Randomized Trial of Transcatheter Indirect Mitral Annuloplasty in Heart Failure Patients with Functional Mitral Regurgitation. Präsentiert auf der TCT 2018 in San Diego.
OTS: Cardiac Dimensions newsroom: http://www.presseportal.de/nr/134425 newsroom via RSS: http://www.presseportal.de/rss/pm_134425.rss2
Pressekontakt: Rick Wypych rwypych@cardiacdimensions.com (425) 605-5910 Foto - https://mma.prnewswire.com/media/444446/Cardiac_Dimensions_Car illon_System.jpg Logo - https://mma.prnewswire.com/media/444443/Cardiac_Dimensions_Logo.jpg
© 2019 news aktuell
